The semaglutide segment has asserted its dominance in the market by securing a significant market share of 58.7% in 2025 stimulated by its broad commercial presence across multiple blockbuster brands, including Ozempic, Wegovy, and Rybelsus, as well as its established global manufacturing network and extensive patient adoption in diabetes and obesity management
Damage to the endothelium is a hallmark of diabetic complications, and reduced glutathione levels correlate with worsening endothelial dysfunction
Related: Americans on Healthy Food and Eating About half (53%) of Americans say they hear or read about Ozempic, Wegovy and similar drugs extremely or very often, as of early 2025
They also have several tendons attached to them, which, in turn, have muscles attached to them
Addressing hormone optimization may help overcome these midlife weight challenges